Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDA) is an extremely lethal malignancy arising from the pancreas. The treatment of PDA is complicated by ineffective treatments and a lack of biomarkers predictive of treatment success. We have designed a patient-derived organoid (PDO) based high-throughput drug scr...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2021-06-01
|
| Schriftenreihe: | Biomedicines |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2227-9059/9/7/705 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|